• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TAFRO综合征中的肾脏受累:综述

Renal involvement in TAFRO syndrome: a review.

作者信息

Ubara Yoshifumi, Sawa Naoki

机构信息

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, 2-2-2, Toranomon, Minato, Tokyo, Japan.

出版信息

Clin Exp Nephrol. 2025 Jan;29(1):21-28. doi: 10.1007/s10157-024-02573-9. Epub 2024 Nov 3.

DOI:10.1007/s10157-024-02573-9
PMID:39488613
Abstract

Renal involvement in TAFRO syndrome is characterized clinically by general edema with ascites and pleural effusions and a rapidly progressive decline in renal function, with urinary protein levels of usually less than 1 g/day. The histologic features of the kidneys can be described as glomerular microangiopathy characterized by mesangiolysis or mesangial loosening, endothelial cell proliferation, edematous opening in the subendothelial space, and glomerular basement membrane (GBM) doubling due to newly formed basement membrane. Findings such as rupture of the GBM, foot-process effacement or fusion, and epithelial cell loss are rare, and thrombus formation is difficult to identify in the glomerulus. Furthermore, immunodeposits are not seen on immunofluorescence staining or electron microscopy. Unlike adults, in addition to the glomerular lesions described above, adolescents appear to show intimal proliferation of the arterioles and interlobular arteries to the vascular poles and occlusion of the vascular lumen.

摘要

TAFRO综合征的肾脏受累在临床上表现为全身性水肿伴腹水和胸腔积液,以及肾功能迅速进行性下降,尿蛋白水平通常低于1g/天。肾脏的组织学特征可描述为肾小球微血管病,其特征为系膜溶解或系膜疏松、内皮细胞增殖、内皮下间隙水肿性开放以及由于新形成的基底膜导致肾小球基底膜(GBM)增厚。GBM破裂、足突消失或融合以及上皮细胞丢失等表现罕见,肾小球内血栓形成难以识别。此外,免疫荧光染色或电子显微镜检查未见免疫沉积物。与成人不同,除上述肾小球病变外,青少年似乎还表现出小动脉和小叶间动脉向血管极的内膜增殖以及血管腔闭塞。

相似文献

1
Renal involvement in TAFRO syndrome: a review.TAFRO综合征中的肾脏受累:综述
Clin Exp Nephrol. 2025 Jan;29(1):21-28. doi: 10.1007/s10157-024-02573-9. Epub 2024 Nov 3.
2
TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.TAFRO 综合征致肾小球微血管病:病例报告并文献复习。
BMC Nephrol. 2019 Oct 17;20(1):375. doi: 10.1186/s12882-019-1574-9.
3
Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.TAFRO综合征患者进行性肾脏受累的病理表现
CEN Case Rep. 2019 Nov;8(4):239-245. doi: 10.1007/s13730-019-00400-9. Epub 2019 May 10.
4
Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome.TAFRO综合征患者肾活检显示血栓性微血管病。
CEN Case Rep. 2018 Nov;7(2):243-247. doi: 10.1007/s13730-018-0338-x. Epub 2018 May 15.
5
Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.TAFRO 综合征的肾脏病理表现:血栓性微血管病与膜增生性肾小球肾炎之间是否存在连续性?病例报告及文献复习。
Front Immunol. 2019 Jun 28;10:1489. doi: 10.3389/fimmu.2019.01489. eCollection 2019.
6
Adolescent-onset TAFRO Syndrome with Malignant Nephrosclerosis-like Lesions.青少年发病的 TAFRO 综合征伴恶性肾硬化样病变。
Intern Med. 2023 Aug 1;62(15):2223-2229. doi: 10.2169/internalmedicine.0529-22. Epub 2022 Dec 14.
7
An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions.一例伴有膜增生性肾小球肾炎样病变的TAFRO综合征尸检病例。
CEN Case Rep. 2019 Feb;8(1):48-54. doi: 10.1007/s13730-018-0363-9. Epub 2018 Sep 22.
8
TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.伴有肾血栓性微血管病的TAFRO综合征:对分子机制和治疗机会的见解
Int J Mol Sci. 2021 Jun 11;22(12):6286. doi: 10.3390/ijms22126286.
9
Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.TAFRO综合征中进行性肾脏受累的临床病理特征:一例报告及文献复习
Medicine (Baltimore). 2017 Oct;96(40):e8216. doi: 10.1097/MD.0000000000008216.
10
Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?与肾小球微血管病和MPGN样病变相关的多中心Castleman病:血管内皮细胞衍生生长因子在肾损伤中起致病作用还是保护作用?
Am J Kidney Dis. 2004 Jan;43(1):E3-9. doi: 10.1053/j.ajkd.2003.09.023.

本文引用的文献

1
Long-term clinicopathological characteristics of TAFRO syndrome and its relapse: a case series study.TAFRO综合征的长期临床病理特征及其复发:一项病例系列研究。
Clin Kidney J. 2024 Apr 30;17(7):sfae110. doi: 10.1093/ckj/sfae110. eCollection 2024 Jul.
2
Adolescent-onset TAFRO Syndrome with Malignant Nephrosclerosis-like Lesions.青少年发病的 TAFRO 综合征伴恶性肾硬化样病变。
Intern Med. 2023 Aug 1;62(15):2223-2229. doi: 10.2169/internalmedicine.0529-22. Epub 2022 Dec 14.
3
Kidney biopsy guidebook 2020 in Japan.《2020年日本肾脏活检指南手册》
Clin Exp Nephrol. 2021 Apr;25(4):325-364. doi: 10.1007/s10157-020-01986-6.
4
Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease.特立昔珠单抗治疗特发性多中心 Castleman 病伴血栓性微血管病样病变膜性肾病一例
CEN Case Rep. 2021 May;10(2):265-272. doi: 10.1007/s13730-020-00559-6. Epub 2021 Jan 2.
5
The Clinical and Histopathological Feature of Renal Manifestation of TAFRO Syndrome.TAFRO综合征肾脏表现的临床和组织病理学特征
Kidney Int Rep. 2020 May 19;5(8):1172-1179. doi: 10.1016/j.ekir.2020.05.004. eCollection 2020 Aug.
6
The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome.抗白细胞介素-6受体单克隆抗体阻断治疗肾移植合并Castleman病患者的疗效和安全性:移植后早期结果
BMC Nephrol. 2018 Oct 11;19(1):263. doi: 10.1186/s12882-018-1065-4.
7
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.特发性多中心 Castleman 病的国际、循证共识治疗指南。
Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4.
8
Renal histology in a patient with TAFRO syndrome: a case report.TAFRO 综合征患者的肾脏组织学:病例报告。
Hum Pathol. 2018 Dec;82:258-263. doi: 10.1016/j.humpath.2018.03.021. Epub 2018 Apr 4.
9
TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report.托珠单抗和罗米司亭治疗反应良好的伴有难治性血小板减少症的TAFRO综合征:一例报告
CEN Case Rep. 2018 May;7(1):162-168. doi: 10.1007/s13730-018-0319-0. Epub 2018 Feb 21.
10
Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.TAFRO综合征的拟诊标准、疾病严重程度分类及治疗策略,2015年版
Int J Hematol. 2016 Jun;103(6):686-92. doi: 10.1007/s12185-016-1979-1. Epub 2016 Mar 18.